Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

The Journal of Chemical Theory and Computation, published by the American Chemical Society, stands at the forefront of the multidisciplinary fields of computational chemistry and computer science applications. With an impressive impact factor and ranking in the top quartile (Q1) in both Physical and Theoretical Chemistry and Computer Science Applications, this journal serves as a vital platform for researchers and professionals seeking to publish cutting-edge research on computational methodologies and innovative theoretical approaches. Spanning from 2005 to 2024, the journal aims to disseminate high-quality studies that advance understanding of molecular systems and the development of computational techniques. Its esteemed reputation is reflected in its robust metrics, ranking #23 in Physical and Theoretical Chemistry and #101 in Computer Science Applications by Scopus, showcasing its significant influence in the academic community. While it does not currently offer open access, the journal remains accessible to a wide audience, making it an essential resource for those engaged in the evolving landscape of chemical theory and computation.

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

Molecular Systems Design & Engineering, published by the esteemed Royal Society of Chemistry, stands at the forefront of interdisciplinary research focused on the integration of molecular systems and engineering principles. With its ISSN 2058-9689 and a robust impact within various scientific domains, this journal not only facilitates the advancement of knowledge in fields such as Biomedical Engineering, Chemical Engineering, and Materials Chemistry, but also fosters collaborative innovations that address contemporary challenges in energy and manufacturing processes. Its recent rankings, including Q1 categorization in Critical areas of Chemical Engineering and Materials Chemistry, underscore its significance and influence within the scientific community, making it a vital resource for researchers, professionals, and students alike. Access options are available to meet diverse reader needs, encouraging wider dissemination of groundbreaking findings and methodologies that enhance the design and application of molecular systems.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Journal of Chemical Information and Modeling is a premier scholarly publication dedicated to advancing the fields of chemical engineering, chemistry, and computer science applications. Published by the reputable American Chemical Society, this journal significantly contributes to the scientific community through innovative research and critical reviews that facilitate the understanding and application of chemical information. With an impressive impact factor and a distinguished ranking in multiple categories—such as Q1 in Chemical Engineering and Q1 in Chemistry—the journal is an indispensable resource for researchers and professionals alike. As open access is not currently available, the journal preserves a selective distribution model that ensures high-quality content is accessible to a dedicated audience. By exploring the intersections of data science and chemical informatics, the Journal of Chemical Information and Modeling fosters interdisciplinary collaboration and innovation, positioning itself as a leader in its field. Researchers, professionals, and students are encouraged to engage with this influential platform for the latest developments in chemical information science.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.